Get started
Author

Renaud Grépin

Observed names: Grépin, Renaud, R GREPIN, R Grepin, R. Grepin, R. Grépin, Renaud Grepin, Renaud Grépin (21365007)
Observed institutions: South Australia Pathology, Centre National de la Recherche Scientifique, Université de Bordeaux, Inserm, Université Côte d'Azur, Institut de Recherche sur le Cancer et le Vieillissement de Nice, Centre de Recherche en Cancérologie de Lyon, Scientific Centre of Monaco, Centre Antoine Lacassagne, Hanson Institute, Université Nice Sophia Antipolis, Université Bordeaux-I
ORCID: 0009-0005-7178-4521
Observed ORCIDs: 0009-0005-7178-4521, 0000-0002-2942-1074
OpenAlex ID: A5040053100
Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux
2015 · Sandy Giuliano, Yann Cormerais, et al. · Autophagy · 147
PDF
The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma
2013 · Renaud Grépin, Mélanie Guyot, et al. · Cancer Research · 121
Assessing IRES activity in the HIF-1α and other cellular 5′ UTRs
2006 · Andrew G. Bert, Renaud Grépin, et al. · RNA · 121
PDF
Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2017 · Maeva Dufies, Sandy Giuliano, et al. · Cancer Research · 110
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines
2011 · R Grepin, M Guyot, et al. · Oncogene · 85
Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins
2016 · Edward Hitti, Tala Bakheet, et al. · Cancer Research · 84
Poly(A)-binding Protein-interacting Protein 2, a Strong Regulator of Vascular Endothelial Growth Factor mRNA
2004 · Cercina Onesto, Edurne Berra, et al. · Journal of Biological Chemistry · 81
PDF
PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion
2007 · Laura Lasagni, Renaud Grepin, et al. · Blood · 78
PDF
Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
2010 · Renaud Grépin, Gilles Pagès · Journal of Oncology · 75
PDF
Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells
2011 · Christine Bourcier, Paola Griseri, et al. · American Journal of Physiology-Cell Physiology · 73
Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression
2016 · Ons Zakraoui, Cezary Marcinkiewicz, et al. · Molecular Carcinogenesis · 69
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments
2019 · Maeva Dufies, Oleksandr Grytsai, et al. · Theranostics · 61
PDF
Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy
2021 · Damien Ambrosetti, Michael Coutts, et al. · British Journal of Urology · 59
NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model
2017 · Wang-Qing Liu, Yves Lepelletier, et al. · Cancer Letters · 46
Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer
2016 · Cathy Quemener, Jessica Baud, et al. · Cancer Research · 42
PDF
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
2019 · Papa Diogop Ndiaye, Maeva Dufies, et al. · Theranostics · 35
PDF
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
2017 · Maeva Dufies, Sandy Giuliano, et al. · British Journal of Cancer · 34
PDF
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
2016 · Mélanie Guyot, Caroline Hilmi, et al. · Oncotarget · 34
PDF
The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma
2014 · Renaud Grépin, Damien Ambrosetti, et al. · PLoS ONE · 33
PDF
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor
2019 · Renaud Grépin, Mélanie Guyot, et al. · Theranostics · 31
PDF
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma
2018 · Maeva Dufies, Marie Nollet, et al. · Theranostics · 22
PDF
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas
2021 · Aurore Dumond, Christopher Montemagno, et al. · Cells · 21
PDF
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
2021 · Marina Pagnuzzi-Boncompagni, Vincent Picco, et al. · Cancers · 20
PDF
Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
2021 · Aurore Dumond, Etienne Brachet, et al. · Journal of Experimental & Clinical Cancer Research · 20
PDF
The ELR+CXCL chemokines and their receptors CXCR1/CXCR2
2014 · Sandy Giuliano, Mélanie Guyot, et al. · OncoImmunology · 18
PDF
Works count: 103
Citation count: 1,552
H-index: 21
I10-index: 27
Year
Topic
Type